Inlog becomes a company with a mission
Inlog is a mission-driven company
Inlog, a leading publisher of software for the healthcare and medical industries, has officially become a mission-driven company under the PACTE Act.
Lyon, 26 May 2023: Inlog is proud to announce that it is now a mission-driven company under the PACTE law (Plan d’Action pour la Croissance et la Transformation des Entreprises). This official recognition underlines Inlog’s deep commitment to social and environmental responsibility, and reinforces its role as a responsible player within the healthcare industry.
As a leading healthcare software company, Inlog has always placed ethics, innovation and patient and donor safety at the heart of its activities. This transition to a mission-driven company is a natural step in the pursuit of Inlog’s mission to provide quality healthcare software solutions while making a positive contribution to society and the environment.
This is reflected in its raison d’être:
To innovate to provide healthcare software solutions that make life easier,
To build strong relationships with healthcare stakeholders,
Provide quality services in an environmentally responsible manner,
Offer our business expertise to support our customers,
Guarantee the safety of patients and donors.
Under the PACTE law, Inlog is officially committed to three main missions that guide its actions:
1- To maintain an innovative approach to our applications and services in order to meet our customers’ expectations.
Inlog remains committed to continuous innovation in order to provide software solutions that meet the expectations of its customers in the healthcare sector. The company invests in research and development to provide state-of-the-art applications and services that facilitate the management of healthcare data, optimise processes and enhance the safety of donors and recipients.
2- ‘To provide our customers with robust and secure services and software solutions to optimise and secure the care of donors and patients’.
Inlog is committed to providing robust and secure software solutions and services. The company implements rigorous measures to ensure the reliability of patient data and blood transfusion chain processes for the safety of donors and recipients, in compliance with European medical device regulations.
3- ‘Developing the expertise of our teams and promoting optimal working conditions for our employees’.
Inlog develops its in-house expertise and promotes optimal working conditions for its employees. The company invests in the continuous training, professional development and well-being of its teams, creating an environment that encourages innovation and collaboration.
By becoming a mission-driven company, Inlog reaffirms its commitment to social and environmental responsibility,’ said David Kalfon, President of Inlog. We are proud to align our actions with our values while continuing to provide superior healthcare software solutions. As a company with a mission, we are committed to playing a positive role in our industry and actively contributing to the safety of donors, patients and society as a whole.
Inlog will continue to work closely with its customers, partners and stakeholders to pursue its mission and achieve its vision as a mission-driven company.
About Inlog :
Founded in 1992, Inlog S.A.S is one of the leading French publishers of medical IT solutions for medical analysis laboratories, hospitals and blood transfusion centres.
Inlog S.A.S is the European leader in transfusion information systems and a major player in the LMS (Laboratory Management Systems) market.
With more than 30 years of experience, these CE-marked medical devices ensure the traceability of blood products and the functional and quality management of analysis laboratories. As such, Inlog publishes the EdgeSuite ™ software suite consisting of 4 different solutions: EdgeLab, EdgeBlood, EdgeTrack, EdgeCell, SapaNet ™.
This software is used by more than 250 customers in France and abroad (Europe: Germany, the Netherlands, Switzerland, Belgium, Canada and Hong Kong), including prestigious partners such as the Etablissement Français du Sang (EFS).
With the acquisition of Viskali in 2022 and Ubilab in May 2023, Inlog has strengthened its Quality division, making the Inlog S.A.S. Group a major player in the field of quality management for analytical laboratories.
Follow our news on our LinkedIn : https://www.linkedin.com/pulse/inlog-devient-soci%25C3%25A9t%25C3%25A9-%25C3%25A0-mission-inlog
